Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization - sprookjes - yvandenbroek - TriplyDB

Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization

Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization

http://www.wikidata.org/entity/Q28203561

about

sameAs

Effects of human recombinant PEDF protein and PEDF-derived peptide 34-mer on choroidal neovascularization MicroRNAs regulate ocular neovascularization Clinical Trials in Retinal Dystrophies Aflibercept: a review of its use in the treatment of choroidal neovascularization due to age-related macular degeneration Microvascular complications and diabetic retinopathy: recent advances and future implications PEDF and its roles in physiological and pathological conditions: implication in diabetic and hypoxia-induced angiogenic diseases Inhibition of oxygen-induced ischemic retinal neovascularization with adenoviral 15-lipoxygenase-1 gene transfer via up-regulation of PPAR-γ and down-regulation of VEGFR-2 expression Blockade of sphingosine-1-phosphate reduces macrophage influx and retinal and choroidal neovascularization Leukostasis and pigment epithelium-derived factor in rat models of diabetic retinopathy The vitreous glycoprotein opticin inhibits preretinal neovascularization Sustained delivery of a HIF-1 antagonist for ocular neovascularization.Autologous transplantation of genetically modified iris pigment epithelial cells: a promising concept for the treatment of age-related macular degeneration and other disorders of the eye.Hypoxia-regulated transgene expression in experimental retinal and choroidal neovascularization.A therapeutic strategy for choroidal neovascularization based on recruitment of mesenchymal stem cells to the sites of lesions.Pigment epithelium-derived factor gene polymorphisms in exudative age-related degeneration in a chinese cohort.Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy.Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1-3 of angiostatin reduce retinal neovascularization The relative contributions of each subset of ocular infiltrated cells in experimental choroidal neovascularisation.Recombinant non-collagenous domain of alpha2(IV) collagen causes involution of choroidal neovascularization by inducing apoptosis.EIAV vector-mediated delivery of endostatin or angiostatin inhibits angiogenesis and vascular hyperpermeability in experimental CNV.Pigment epithelium-derived factor binds to cell-surface F(1)-ATP synthase.Alternate serotype adenovector provides long-term therapeutic gene expression in the eye.An empty E1, E3, E4 adenovirus vector protects photoreceptors from light-induced degeneration Animal models of choroidal and retinal neovascularization.Constitutive overexpression of pigment epithelium-derived factor inhibition of ocular melanoma growth and metastasis Modulation of thrombospondin 1 and pigment epithelium-derived factor levels in vitreous fluid of patients with diabetes Multi-gene targeted antiangiogenic therapies for experimental corneal neovascularization.Regulation of angiogenesis by histone chaperone HIRA-mediated incorporation of lysine 56-acetylated histone H3.3 at chromatin domains of endothelial genes.Overexpression of pigment epithelium-derived factor inhibits retinal inflammation and neovascularization.Anti-angiogenic and anti-inflammatory effects of SERPINA3K on corneal injury.Vascular endothelial growth factor-B gene transfer exacerbates retinal and choroidal neovascularization and vasopermeability without promoting inflammation.Digoxin inhibits retinal ischemia-induced HIF-1alpha expression and ocular neovascularization.Oxidative stress promotes ocular neovascularization.Ocular localization and transduction by adenoviral vectors are serotype-dependent and can be modified by inclusion of RGD fiber modifications Characterization of a mouse model of hyperglycemia and retinal neovascularization Polarized secretion of PEDF from human embryonic stem cell-derived RPE promotes retinal progenitor cell survival.Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A Efficient gene transfer to retinal pigment epithelium cells with long-term expression.Comparison of the effects between intravitreal and periocular injections of adenoviral vectored pigment epithelium-derived factor on suppressing choroidal neovascularization in rats.The pathogenesis of diabetic retinopathy: old concepts and new questions.

P2860

Q24630406-86A69F46-2000-4E17-87DB-B2AB9179B688 Q24631030-DCCD5A6D-42A1-4992-8B54-9770FF49267A Q26767086-CF795EFA-71B1-46EE-9D03-65016F4EB64D Q26771522-7513D5B1-95CE-46CB-A5D7-DFAECAD0A92D Q26822476-A18F8510-E375-488D-8EE5-88CCBBEB28BE Q27026916-0A25163B-51F1-4C00-AAFF-E1DF3991F442 Q27332433-3A996919-833F-4F68-8C15-F0A3CD64C614 Q28293429-52922E35-C131-4D91-9950-5F8A15EAD4FD Q28576755-ED8965DB-AAF1-4184-B3A9-71624C3D3985 Q28594681-55A4F893-D23B-47E8-9C2A-C352A299E92D Q30560557-B2CDBEF1-42B7-478D-9F3C-24935EB07164 Q30850268-35800E46-0F5B-4403-BC13-6596573809E4 Q30939880-EC8A0FD9-98A5-447D-ABED-AA2FE13C2E04 Q30986055-540A02C9-3E20-469D-8F13-DEC2F5CD7500 Q30993369-79181D40-3DDE-4DE0-A9B4-11B1B913F022 Q31065469-DE451E8B-7875-4B2A-8055-91032B67849F Q31081886-085222FF-AA43-4C8F-82D8-706A4ADBCA7A Q33206080-81F33B67-965F-40BD-BAA3-57C087F9D751 Q33237435-2529ED54-2083-46C8-B92F-DABA5A6148CE Q33237979-DCF9B29A-00B4-4044-A985-0400F1D7DCF2 Q33285670-538889DF-95BB-4295-BDD7-C85A3D492160 Q33397385-D88924D0-8AA7-46D3-B37A-4C9ABB927F9B Q33574612-4E0B7BD6-29F9-42BF-84EC-448D8E1B8510 Q33582933-A651DD3C-9C81-4669-A6D8-25A05AEF28F5 Q33640617-867B08E1-C916-4B97-885C-63252588C57F Q33642146-45E8CEBC-FC51-4AD3-A82B-9F903200AA59 Q33694084-A0AECD6D-2060-4AFF-BE96-09FD82C1A573 Q33735558-D418B8FC-AAAD-4F23-B282-DE08B907900B Q33808055-E979FC0A-4B49-4A3B-AAF4-838AF906298B Q33815623-26E28CA1-B7F2-4361-8683-D02AEC94555B Q33834038-29FA6789-72F3-412A-B426-419F09B1EB61 Q33868764-45AF3027-9CD7-457C-80A0-09EBFFC5B11A Q34000654-B9D99C35-6963-401E-BA6F-2E5B758DB347 Q34215308-9153DFC2-C0B5-4593-8AE9-2AD40B351DFF Q34254645-C1837E6F-7E7E-4B7E-B00F-525B828A91D1 Q34281455-FDAC7C7E-551E-41F5-827C-168E4E37CAD9 Q34331369-7E54A707-D9C5-4A96-88CF-90C78598BA87 Q34406695-FD29CD01-A80D-4821-AFA3-3A6120F8E98D Q34519469-F64CC58E-02DE-42E9-9E7C-37CFBAB0B33C Q34658478-2A357794-5381-4DFF-B9C8-89D4ABF23524

P2860

Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization

http://www.wikidata.org/entity/Q28203561

description

2001 nî lūn-bûn

@nan

2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization

@ast

Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization

@en

Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization

@nl

type

label

Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization

@ast

Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization

@en

Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization

@nl

prefLabel

Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization

@ast

Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization

@en

Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization

@nl

P1433

Q28203561-3613C7AB-F169-420C-8EA4-A8C38ED63436

P1476

Q28203561-4CFD7D58-7328-4AC9-99D3-2D42FD0F9C44

P2093

Q28203561-0B681105-845A-4E31-9158-581A1CEEFDDF

Q28203561-0D847BA6-2D85-43CF-B8F2-11025FE9D243

Q28203561-15B14A8A-935B-4F9E-B0F4-44ED6F1E2F43

Q28203561-179A1197-CF84-4C29-9C45-D161235B98EC

Q28203561-254254E3-369F-4983-91EC-04B55B462382

Q28203561-403A9E95-321C-496E-8F30-EF84EC4CD722

Q28203561-68714A23-E509-4B87-BE6E-3926BF33507B

Q28203561-AC8747F8-62D9-4F59-8DC5-208B6FAEF9EB

Q28203561-B9F0391C-141F-4CDC-A17E-34BCDC8297DA

Q28203561-C115501C-6AA5-40EA-B25E-22A273115CE9

P304

Q28203561-08B349F3-5C53-498F-A592-FEF25FE3C929

P31

Q28203561-1A087E86-EE38-4A69-AE02-48BB6DBB53F8

P3181

Q28203561-87290690-3DFE-4B7C-B87B-43FBC686B0B7

P356

Q28203561-3F8FD79D-6B79-4A56-92BC-18084B5598D0

P407

Q28203561-8388C3AB-8F63-4F0C-A907-4B5DEE568837

P433

Q28203561-086A23AE-CE00-4FBD-98C6-038DBD447713

P478

Q28203561-E39D69BD-89A8-4EB5-8FE6-C065A3AF757B

P50

Q28203561-3D0733F9-C679-4602-8B1C-75092D95C778

P577

Q28203561-395461EC-5F9D-425D-BB01-0CFFBD82CDA6

P5875

Q28203561-D9304C44-CECD-48F1-9999-F2BFEE14A983

P698

Q28203561-E1596AD0-5A37-4EF3-B6C9-D9214F494A2D

P921

Q28203561-C8A10E23-CDF1-4575-B76D-BDD5D8B48307

P3181

P356

P1433

Journal of Cellular Physiology

P1476

Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization

@en

P2093

Ando A

http://www.w3.org/2001/XMLSchema#string

Brough DE

http://www.w3.org/2001/XMLSchema#string

Campochiaro PA

http://www.w3.org/2001/XMLSchema#string

Duh E

http://www.w3.org/2001/XMLSchema#string

Ettyreddy D

http://www.w3.org/2001/XMLSchema#string

Gehlbach P

http://www.w3.org/2001/XMLSchema#string

Mori K

http://www.w3.org/2001/XMLSchema#string

Pearlman J

http://www.w3.org/2001/XMLSchema#string

Takahashi K

http://www.w3.org/2001/XMLSchema#string

Wei LL

http://www.w3.org/2001/XMLSchema#string

P304

253-263

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1651673

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/JCP.1114

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

188

http://www.w3.org/2001/XMLSchema#string

P50

P577

2001-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227608779

http://www.w3.org/2001/XMLSchema#string

P698

11424092

http://www.w3.org/2001/XMLSchema#string

P921

neovascularization